dupixent dosing - Yahoo Search Results

Ads
related to: dupixent dosing
FDA Approved For Mild Symptoms - Mild To Moderate Symptoms

www.psoriasishelp.com
A Treatment Option That Has Data In Mild to Moderate Plaque Psoriasis. Visit Official Website with Patient Resources, Including Support Information.
Types: Prescribing Information, Safety & Efficacy Info, Patient Support Program
About Psoriasis
Information On Plaque Psoriasis

& Options Available For Treatment.

Therapy Information
Alternate Therapy For Plaque

Psoriasis.

Patient Resources
Get Tools, Personalized Info,

Talk to a Nurse and More.

About Plaque Psoriasis
Information On Plaque Psoriasis.

Learn About A Therapy Option.

Patient Stories
Real People Telling Their Plaque

Psoriasis Treatment Stories.

Co-Pay Program
Learn More and See If You Are

Eligible for a Co-Pay Card.
Official HCP Website - Severe Asthma Treatment Info

www.hcp-asthma-medication.com
Healthcare Professionals - Need Something Different To Help Your SEA Patients? Learn More. Register For Updates & Explore Resources To Learn More About A Severe Asthma Treatment.
Patient Assistance · Eosinophil Calculator
Dosing & Administration
Eosinophil Diseases
Prescribing Information
Adverse Reaction Info

Search results

- Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study
  Zacks via Yahoo Finance· 6 months ago
  Regeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced positive study data on the...
- Sanofi (SNY) Dupixent Esophagitis Kids Study Meets Goal
  Zacks via Yahoo Finance· 2 years ago
  Sanofi's (SNY) Dupixent shows the potential to improve signs of eosinophilic esophagitis in a phase...
- Regeneron-Sanofi's Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years
  Benzinga via Yahoo Finance· 2 years ago
  Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's (NASDAQ: SNY) Phase 3 trial of Dupixent...
- Pharma Stock Roundup: MRK Buys Cancer Drug Rights, SNY Dupixent Kids Study Succeeds
  Zacks via Yahoo Finance· 2 years ago
  This week, Merck MRK in-licensed co-development rights to Orion Corporation’s prostate cancer...
- Regeneron (REGN), Sanofi's Dupixent Gets Label Update in US
  Zacks via Yahoo Finance· 4 months ago
  The FDA updates Regeneron (REGN) and Sanofi's Dupixent label in the United States to include...
- Regeneron (REGN) Q3 Earnings & Sales Beat on Eylea, Dupixent
  Zacks via Yahoo Finance· 2 years ago
  Regeneron (REGN) tops earnings and sales estimates for the third quarter, driven by its lead drug...
- Regeneron Jumps On Third-Quarter Beat As High-Dose Eylea Delivers
  Investor's Business Daily· 7 months ago
  Regeneron Pharmaceuticals' high-dose Eylea is off to a strong start in the U.S., the company said...
- US FDA approves Dupixent to treat younger kids with esophageal condition
  Reuters via Yahoo News· 4 months ago
  (Reuters) -The U.S. health regulator has approved the use of Regeneron and Sanofi's Dupixent to...
- Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
  Zacks via Yahoo Finance· 1 year ago
  This week, Sanofi SNY and partner Regeneron’s REGN blockbuster medicine, Dupixent succeeded in a...
- Sanofi - Regeneron Tout Additional Positive Data From Flagship Dupixent Product
  Benzinga via Yahoo Finance· 2 years ago
  Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) presented more positive...